G. Carpenter and S. Cohen. Epidermal growth factor (EGF). Annu. Rev. Biochem.
H. Gregory. Isolation and structure of urogastron and its relationship to EGF. Nature
G. Carpenter and J. G. Zendegui. Epidermal growth factor, its receptor, and related proteins. Exp. Cell Res.
G. Singh and C. Foster. Epidermal growth factor in alkali-burned corneal epithelial wound healing. Am. J. Ophthal.
G. Arturson. Epidermal growth factor in the healing of corneal wound, epidermal wound and partial-thickness scalds. Scand. J. Plast. Reconstr. Surg.
G. L. Brown, L, Curtsinger, J. R. Brightwell, D. M. Ackerman, G. R. Tobin, H. C. Polk, C. George-Nascimento, P. Valenzuela, and G. S. Schultz. Enhancement of epidermal regeneration by biosynthetic EGF. Chiron, wound healing efficacy. J. Exp. Med.
M. C. Manning, K. Patel, and R. T. Borchardt. Stability of protein pharmaceuticals. Pharm. Res.
A. B. Robinson and C. J. Rudd. Deamidation of glutaminyl and asparaginyl residues in peptides and proteins. Current Topics in Cellular Regulation, vol. 8, Academic Press, New York, 1974, pp. 247–295.
T. Geiger and S. Clarke. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J. Biol. Chem.
J. W. Scotchler and A. B. Robinson. Deamidation of glutaminyl residues: Dependence on pH, temperature, and ionic strength. Anal. Biochem.
A. J. Brake, J. P. Merryweather, D. G. Coit, U. A. Heberlein, F. R. Masiarz, G. T. Mullenbach, M. S. Urdea, P. Valenzuela, and P. J. Barr. α-factor-directed synthesis and secretion of mature foreign proteins in saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 81:4642–4646 (1984).
W. F. Heath and R. B. Merrifield. A synthetic approach to structure-function relationships in the murine epidermal growth factor molecule. Proc. Natl. Acad. Sci. USA 83:6367–6371 (1986).
A. W. Burgess, J. Knesel, L. G. Sparrow, N. A. Nicola and E. C. Nice. Two forms of murine EGF (mEGF): Rapid separation by using reverse phase HPLC (RP-HPLC). Proc. Natl. Acad. Sci. USA 79:5753–5757 (1982).
R. P. DiAugustine, M. P. Walker, D. G. Klapper, R. I. Grove, W. D. Willis, D. J. Harvan, and O. Hernandez. β-Epidermal growth factor is the desasparaginyl form of the polypeptide. J. Biol. Chem.
F. Araki, H. Nakamura, N. Nouma, K. Tsukumo, and S. Sakamoto. Stability of recombinant human epidermal growth factor in various solutions. Chem. Pharm. Bull.
M. W. Riemen, R. J. Wegrzyn, A. E. Baker, W. M. Hurni, C. D. Bennett, A. Oliff, and R. B. Stein. Isolation of multiple biologically and chemically diverse species of epidermal growth factor. Peptides
A. S. Chawla, I. Hinberg, P. Blais, and D. Johnson. Aggregation of insulin, containing surfactants, in contact with different materials. Diabetes
A. A. Kossiakoff. Tertiary structure is a principal determinant to protein deamidation. Science
T. Arakawa and S. N. Timasheff. Stabilization of protein structure by sugars. Biochemistry 21:6536–6544 (1982).
J. Brange, L. Langkjaer, S. Havelund and A. Volund. Chemical stability of insuline. 1. Hydrolytic degradation during storage of pharmaceutical preparation. Pharm. Res.
M. A. Scheinberg, J. R. Wohigethan and E. S. Cathcart. Humoral and cellular aspects of amyloid disease present status. Prog. Allergy